Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 20, 2018 08:00 ET | Source: Pascal Biosciences Inc.

Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones

- 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic- Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE)...
December 10, 2018 20:45 ET | Source: Pascal Biosciences Inc.

Pascal Biosciences Announces Year-End Investor Update Webcast

Advancement of Cannabinoid Cancer Programs and Corporate Review to be Presented Scheduled for Dec. 17, 2018 at 1:30 p.m. Pacific VANCOUVER, British Columbia and SEATTLE, Dec. 10, 2018 (GLOBE...
November 28, 2018 08:00 ET | Source: Pascal Biosciences Inc.

Pascal Biosciences Expands Leadership Team to Support Strategic Advancement of Its Cannabinoid Based Programs

VANCOUVER, B.C. and SEATTLE, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the...
November 05, 2018 08:00 ET | Source: Pascal Biosciences Inc.

Pascal Biosciences Announces Optimization of Cannabinoid-Derived Drug Candidates to Kill Glioblastoma Cells

VANCOUVER, British Columbia and SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced...
October 30, 2018 08:00 ET | Source: Pascal Biosciences Inc.

Pascal Biosciences and the University of Washington Enter Into Exclusive License Agreement to Develop Cannabinoid-based Medicine for Cancer

Program Developed in Lab of Renowned Cannabis Researcher Dr. Nephi Stella-Lead Candidate for Glioblastoma to Begin Clinical Testing in 2019 VANCOUVER, B.C. and SEATTLE, Oct. 30, 2018 (GLOBE...
July 16, 2018 09:00 ET | Source: Pascal Biosciences Inc.

Pascal Biosciences appoints Julie M. Eastland, accomplished financial executive, to Board of Directors

VANCOUVER, British Columbia, July 16, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the...
June 18, 2018 08:30 ET | Source: Pascal Biosciences Inc.

Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration

VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX-V:PAS) (Pascal), is pleased to announce significant progress in its cannabinoid based research and...
March 08, 2018 20:35 ET | Source: Pascal Biosciences Inc.

Pascal Announces Oversubscription of Financing

VANCOUVER, British Columbia, March 08, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Pascal...
February 23, 2018 11:14 ET | Source: Pascal Biosciences Inc.

Pascal Biosciences Inc. Announces Non-Brokered Private Placement

VANCOUVER, British Columbia, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) arranges a non-brokered private placement of up to 12,500,000 units...
February 21, 2018 09:30 ET | Source: Pascal Biosciences Inc.

Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells

VANCOUVER, British Columbia and SEATTLE, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) today announced the Company has discovered certain...